Fredun Pharmaceuticals Ltd Q4 FY2023-2024 Results: Summary

Revenue
₹118.03Cr
Net Profits
₹5.06Cr
Net Profit Margins
4.29%

Highlights

Revenue:

Fredun Pharmaceuticals Ltd’s revenue jumped 47.91% since last year same period to ₹118.03Cr in the Q4 2023-2024. On a quarterly growth basis, Fredun Pharmaceuticals Ltd has generated 35.65% jump in its revenue since last 3-months.

Net Profits:

Fredun Pharmaceuticals Ltd’s net profit jumped 30.08% since last year same period to ₹5.06Cr in the Q4 2023-2024. On a quarterly growth basis, Fredun Pharmaceuticals Ltd has generated 19.91% jump in its net profits since last 3-months.

Net Profit Margins:

Fredun Pharmaceuticals Ltd’s net profit margin fell -12.05% since last year same period to 4.29% in the Q4 2023-2024. On a quarterly growth basis, Fredun Pharmaceuticals Ltd has generated -11.61% fall in its net profit margins since last 3-months.

FAQs

The revenue for Fredun Pharmaceuticals Ltd in the Q4 results 2023 was ₹118.03Cr.

The net profit for Fredun Pharmaceuticals Ltd in the Q4 results 2023 was ₹5.06Cr.

The net profit margin for Fredun Pharmaceuticals Ltd in the Q4 results 2023 was 4.29%.

The revenue for Fredun Pharmaceuticals Ltd in the Q4 results 2022 was ₹79.80Cr.

The net profit for Fredun Pharmaceuticals Ltd in the Q4 results 2022 was ₹3.89Cr.

The net profit margin for Fredun Pharmaceuticals Ltd in the Q4 results 2022 was 4.87%.